speb/financial-data huggingface dataset:
Financial ratios for ASP.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -3942068.9655172415
Buffett classification: The Gruesome
Stock price: 1.0344827586206897
Shares outstanding: 11756686
Book value: 2080000.000000001
P/B ratio: 5.847158156498672
Market cap (USD): 12162088.965517242
Debt to equity: 0.08720159151193631
Current ratio: 0.26730185320908806
Quick ratio: 0.26730185320908806
Buyback yield (%): 0
Retained earnings: -5710344.827586207
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASP.AX — annual report dated 2024-09-30
Total revenue: 12059310.344827587
Gross profit: 6277241.379310345
Operating income: -1593103.448275862
Net income: -1290344.8275862068
Capital expenditures: 7586.206896551725
Depreciation & amortization: 635862.0689655172
Net tangible assets: -3942068.9655172415
Owner earnings: -662068.9655172414
Buffett classification: The Gruesome
Stock price: 1.0344827586206897
Shares outstanding: 11756686
Book value: 2080000.000000001
P/B ratio: 5.847158156498672
Market cap (USD): 12162088.965517242
Debt to equity: 0.08720159151193631
Current ratio: 0.26730185320908806
Quick ratio: 0.26730185320908806
Interest coverage ratio: -177.6923076923077
COGS to revenue (%): 47.946928971748825
SG&A to revenue (%): 58.89854740935606
Free cash flow (dilution-adjusted): -1696551.7241379311
Buyback yield (%): 0.017011596635310326
Retained earnings: -5710344.827586207
Receivables turnover: 15.100172711571677
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.83818770226536
FCF margin (%): -14.06839757520302
Revenue growth (%): -2.2624473299509766
Rule of 40 score: -16.330844905153995
Financial ratios for ATHM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.59
Shares outstanding: 115170911
Market cap (USD): 2832052701.49
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATHM — annual report dated 2022-12-31
Total revenue: 997245402.2988505
Gross profit: 819778017.2413793
Operating income: 179241666.66666666
Net income: 279423275.86206895
Capital expenditures: 16491666.666666666
Operating cash flow: 368545258.62068963
Depreciation & amortization: 60922126.43678161
Net tangible assets: 2825939224.137931
Owner earnings: 323853735.63218385
Return on net tangible assets (%): 11.460038944431911
Capex to operating income (%): 9.200799665256405
Buffett classification: The Great
Stock price: 26.01
P/E ratio: 10.720636589303709
Shares outstanding: 115170911
Book value: 3604687643.6781607
P/B ratio: 0.8310277314495264
Market cap (USD): 2995595395.11
Debt to equity: 0.004399961958857373
Current ratio: 6.01795536278333
Quick ratio: 6.01795536278333
Effective tax rate (%): -3.5045602395217736
COGS to revenue (%): 17.79575866164671
R&D to revenue (%): 20.416786008816242
SG&A to revenue (%): 48.40514705161978
Free cash flow (dilution-adjusted): 327391235.6321839
Buyback yield (%): 3.4491876661720404
Retained earnings: 2327112500
Receivables turnover: 3.4442634299084203
Capitalized R&D asset: 203605459.77011496
ROCI (R&D-adjusted, %): 8.097186019806704
FCF margin (%): 32.82955578210554
Rule of 40 score: 32.82955578210554
Financial ratios for ATHM — annual report dated 2023-12-31
Total revenue: 1010426863.5724331
Gross profit: 811850070.323488
Operating income: 159975386.77918425
Net income: 285988888.8888889
Capital expenditures: 10920675.10548523
Operating cash flow: 344786075.94936705
Depreciation & amortization: 49588466.947960615
Net tangible assets: 2782590576.6526017
Owner earnings: 324656680.73136425
Return on net tangible assets (%): 11.667425436404642
Capex to operating income (%): 6.826472075081873
Buffett classification: The Great
Stock price: 25.37
P/E ratio: 10.216781579948716
Shares outstanding: 115170911
Book value: 3540539803.094233
P/B ratio: 0.8252656867510529
Market cap (USD): 2921886012.07
Debt to equity: 0.007791607897243891
Current ratio: 5.029206452913305
Quick ratio: 5.029206452913305
Effective tax rate (%): 3.6121495982106206
COGS to revenue (%): 19.652762649922366
R&D to revenue (%): 18.770137253823876
SG&A to revenue (%): 49.75988062585127
Free cash flow (dilution-adjusted): 306250492.26441634
Buyback yield (%): 3.050834715339307
Retained earnings: 2334946272.8551335
Receivables turnover: 4.694442248140783
Capitalized R&D asset: 326074167.1880305
ROCI (R&D-adjusted, %): 5.533937353758188
Rosenberg metric: -0.03893779138753194
FCF margin (%): 30.309021197402338
Revenue growth (%): 1.3217871191179893
Rule of 40 score: 31.630808316520326
Financial ratios for ATHM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.11
Shares outstanding: 115170911
Market cap (USD): 3467796130.21
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATHM — quarterly report dated 2024-12-31
Total revenue: 244306301.36986303
Gross profit: 185599726.02739727
Operating income: 31836849.315068495
Net income: 47728493.15068493
Capital expenditures: 0
Net tangible assets: 2723575342.4657536
Owner earnings: 47728493.15068493
Return on net tangible assets (%): 1.7524205189592648
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.05
P/E ratio: 15.111682404478959
Shares outstanding: 115170911
Book value: 3452143835.6164384
P/B ratio: 0.8357216436883572
Market cap (USD): 2885031320.55
Debt to equity: 0.0037362131532321587
Current ratio: 5.555186615550288
Quick ratio: 5.555186615550288
Effective tax rate (%): 9.118465947070757
COGS to revenue (%): 24.029906315673788
R&D to revenue (%): 18.39073563615403
SG&A to revenue (%): 45.62468179402008
Buyback yield (%): 0
Retained earnings: 2293360958.9041095
Receivables turnover: 1.2147745315270335
Capitalized R&D asset: 44929726.02739726
ROCI (R&D-adjusted, %): 1.7335517104693048
Rule of 40 score: 0
Financial ratios for ATHM — annual report dated 2024-12-31
Total revenue: 964326986.3013699
Gross profit: 761146164.3835616
Operating income: 137465342.46575344
Net income: 245501095.89041096
Capital expenditures: 18634657.534246575
Operating cash flow: 188100684.93150684
Depreciation & amortization: 41713424.65753425
Net tangible assets: 2723575342.4657536
Owner earnings: 268579863.01369864
Return on net tangible assets (%): 9.861297347865667
Capex to operating income (%): 13.555895035062385
Buffett classification: The Great
Stock price: 25.05
P/E ratio: 11.75160261540277
Shares outstanding: 115170911
Book value: 3452143835.6164384
P/B ratio: 0.8357216436883572
Market cap (USD): 2885031320.55
Debt to equity: 0.0037362131532321587
Current ratio: 5.555186615550288
Quick ratio: 5.555186615550288
Effective tax rate (%): 3.733540966418946
COGS to revenue (%): 21.06970195836773
R&D to revenue (%): 18.72898225421463
SG&A to revenue (%): 49.54388659448345
Free cash flow (dilution-adjusted): 142618493.15068495
Buyback yield (%): 1.0591371448383142
Retained earnings: 2293360958.9041095
Receivables turnover: 4.794963766610517
Capitalized R&D asset: 374869632.9863
ROCI (R&D-adjusted, %): 3.2556082962136736
Rosenberg metric: -0.26734316413902304
FCF margin (%): 14.789432959632434
Revenue growth (%): -4.562416037522394
Rule of 40 score: 10.227016922110039
Financial ratios for ATHM — quarterly report dated 2025-03-31
Total revenue: 200250413.2231405
Gross profit: 156790358.12672177
Operating income: 32142561.983471077
Net income: 53182369.14600551
Capital expenditures: 0
Net tangible assets: 2748293388.4297523
Owner earnings: 53182369.14600551
Return on net tangible assets (%): 1.935105231846861
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.76
P/E ratio: 14.487759890401033
Shares outstanding: 115170911
Book value: 3478596005.509642
P/B ratio: 0.8859820380057231
Market cap (USD): 3081973578.36
Debt to equity: 0
Current ratio: 7.367162639161202
Quick ratio: 7.367162639161202
Effective tax rate (%): 14.124978058627347
COGS to revenue (%): 21.70285413992673
R&D to revenue (%): 18.856624419287694
SG&A to revenue (%): 46.406221411483415
Buyback yield (%): 0
Receivables turnover: 0.8834008018443149
Capitalized R&D asset: 67863384.75791539
ROCI (R&D-adjusted, %): 1.1710959923469046
Rosenberg metric: -0.641209516459284
Revenue growth (%): -18.033054366463077
Rule of 40 score: -18.033054366463077
Financial ratios for ATHM — quarterly report dated 2025-06-30
Total revenue: 245205020.9205021
Gross profit: 174992468.61924687
Operating income: 41372803.34728034
Net income: 62234449.09344491
Capital expenditures: 0
Net tangible assets: 2799443654.1143656
Owner earnings: 62234449.09344491
Return on net tangible assets (%): 2.2231006150803725
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.9
P/E ratio: 17.577922769979157
Shares outstanding: 115170911
Book value: 3536603486.7503486
P/B ratio: 0.8108784868430564
Market cap (USD): 2867755683.8999996
Debt to equity: 0
Current ratio: 7.774855367299862
Quick ratio: 7.774855367299862
Effective tax rate (%): 13.131820979360445
COGS to revenue (%): 28.6342229199372
R&D to revenue (%): 14.391338475189405
SG&A to revenue (%): 43.37855208973222
Buyback yield (%): 0
Receivables turnover: 1.1380883362970375
Capitalized R&D asset: 75414607.88197424
ROCI (R&D-adjusted, %): 1.0142200631754659
Rosenberg metric: 0.48204143917083625
Revenue growth (%): 22.449195971080638
Rule of 40 score: 22.449195971080638
Financial ratios for ATHM — quarterly report dated 2025-09-30
Total revenue: 249732303.37078652
Gross profit: 159007584.26966292
Operating income: 20650280.898876403
Net income: 65730758.426966295
Capital expenditures: 0
Net tangible assets: 2816227247.1910114
Owner earnings: 65730758.426966295
Return on net tangible assets (%): 2.3340005140752793
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 27.56
P/E ratio: 13.868248916090177
Shares outstanding: 115170911
Book value: 3556480196.6292133
P/B ratio: 0.8924864280611997
Market cap (USD): 3174110307.16
Debt to equity: 0
Current ratio: 8.00622464973461
Quick ratio: 8.00622464973461
Effective tax rate (%): 4.1650718299364256
COGS to revenue (%): 36.32878801683151
R&D to revenue (%): 15.669531532078732
SG&A to revenue (%): 41.94592636834722
Buyback yield (%): 0
Receivables turnover: 1.249424859289032
Capitalized R&D asset: 75235987.19554153
ROCI (R&D-adjusted, %): 0.604960247026602
Rosenberg metric: -0.4529799214539614
Revenue growth (%): 1.846325345740865
Rule of 40 score: 1.846325345740865
Financial ratios for ATHM — annual report dated 2025-12-31
Total revenue: 921718571.4285715
Gross profit: 666885571.4285715
Operating income: 109898142.85714285
Net income: 224970571.42857143
Capital expenditures: 16035428.57142857
Operating cash flow: 127066000
Depreciation & amortization: 39060285.71428572
Net tangible assets: 2720834142.857143
Owner earnings: 247995428.57142857
Return on net tangible assets (%): 9.114683789986884
Capex to operating income (%): 14.59117338522554
Buffett classification: The Great
Stock price: 21.49
P/E ratio: 11.001540608949488
Shares outstanding: 115170911
Book value: 3470739714.285714
P/B ratio: 0.7131110602165581
Market cap (USD): 2475022877.39
Debt to equity: 0.0017347063684818444
Current ratio: 5.9960416421397715
Quick ratio: 5.9960416421397715
Effective tax rate (%): 9.25308789862305
COGS to revenue (%): 27.647593083107175
R&D to revenue (%): 16.486997115636477
SG&A to revenue (%): 46.55919144827286
Free cash flow (dilution-adjusted): 78918714.28571428
Buyback yield (%): 6.071995822227097
Retained earnings: 2378111285.714286
Receivables turnover: 4.030324741968591
Capitalized R&D asset: 335558804.4943728
ROCI (R&D-adjusted, %): 2.2655088318108123
Rosenberg metric: -0.5219052538269975
FCF margin (%): 8.562126958492133
Revenue growth (%): -4.41846131841866
Rule of 40 score: 4.143665640073473
Financial ratios for ATHM — quarterly report dated 2025-12-31
Total revenue: 208856857.14285713
Gross profit: 163295857.14285713
Operating income: 13179857.142857144
Net income: 39209428.571428575
Capital expenditures: 0
Net tangible assets: 2720834142.857143
Owner earnings: 39209428.571428575
Return on net tangible assets (%): 1.4410811726382862
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.49
P/E ratio: 11.231877446866509
Shares outstanding: 115170911
Book value: 3470739714.285714
P/B ratio: 0.7131110602165581
Market cap (USD): 2475022877.39
Debt to equity: 0.0017347063684818444
Current ratio: 5.9960416421397715
Quick ratio: 5.9960416421397715
Effective tax rate (%): 2.794388624274241
COGS to revenue (%): 21.81446212648718
R&D to revenue (%): 17.64496257860818
SG&A to revenue (%): 56.146862034010994
Buyback yield (%): 0
Retained earnings: 2378111285.714286
Receivables turnover: 0.9132515986609789
Capitalized R&D asset: 74716209.13198386
ROCI (R&D-adjusted, %): 0.35809658007762574
Rosenberg metric: 0.10958514263974398
Revenue growth (%): -16.367704808792855
Rule of 40 score: -16.367704808792855
Financial ratios for AXIA3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.028070175438597
Shares outstanding: 1976305770
Market cap (USD): 9937004099.68421
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXIA3.SA — annual report dated 2022-12-31
Total revenue: 6453453219.696969
Gross profit: 5538277462.121212
Operating income: 1195519507.5757575
Net income: 689087500
Capital expenditures: 300310416.6666666
Operating cash flow: 983994128.7878788
Depreciation & amortization: 509520643.93939394
Net tangible assets: 5781101325.757575
Owner earnings: 898297727.2727274
Return on net tangible assets (%): 15.53852244848885
Capex to operating income (%): 25.119658421603514
Buffett classification: The Good
Stock price: 6.990512333965846
P/E ratio: 20.048817981566735
Shares outstanding: 1976305770
Book value: 21028150757.575756
P/B ratio: 0.6569949978076715
Market cap (USD): 13815389860.872868
Debt to equity: 0.5507524383169041
Current ratio: 1.8767580544608282
Quick ratio: 1.8605214517098454
Effective tax rate (%): 20.781875054149577
Interest coverage ratio: 1.3416158876776556
COGS to revenue (%): 14.181179074522381
SG&A to revenue (%): 17.29768062570917
Free cash flow (dilution-adjusted): -5384265530.30303
Buyback yield (%): 0
Inventory turnover: 11.255568237404205
Receivables turnover: 1.7343374478223712
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.589396751991596
FCF margin (%): -83.43231673035751
Rule of 40 score: -83.43231673035751
Financial ratios for AXIA3.SA — annual report dated 2023-12-31
Total revenue: 9082201855.670103
Gross profit: 6522456701.030929
Operating income: 2240357938.14433
Net income: 938097731.958763
Capital expenditures: 796447422.6804124
Operating cash flow: 1698007835.0515466
Depreciation & amortization: 746668453.6082475
Net tangible assets: 6694253814.43299
Owner earnings: 888318762.886598
Return on net tangible assets (%): 13.269869764593615
Capex to operating income (%): 35.55000784116235
Buffett classification: The Good
Stock price: 7.732919254658385
P/E ratio: 16.291066933948475
Shares outstanding: 1976305770
Book value: 23188586391.752575
P/B ratio: 0.6590575502852124
Market cap (USD): 15282612941.925465
Debt to equity: 0.5497830322567865
Current ratio: 1.7635309122960483
Quick ratio: 1.7478205557620086
Effective tax rate (%): -173.4863400751109
Interest coverage ratio: 1.6810695612419424
COGS to revenue (%): 12.542925521103598
SG&A to revenue (%): 10.861515279493398
Free cash flow (dilution-adjusted): 848288041.2371135
Buyback yield (%): 2.6540746684106193
Inventory turnover: 12.948494222972181
Receivables turnover: 1.9322443570631462
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.529317545442246
FCF margin (%): 9.340114376642262
Revenue growth (%): 40.73398452707108
Rule of 40 score: 50.07409890371334
Financial ratios for AXIA3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.447513812154696
Shares outstanding: 1976305770
Market cap (USD): 12742258749.116022
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXIA3.SA — annual report dated 2024-12-31
Total revenue: 7667993689.320389
Gross profit: 5539638673.139159
Operating income: 2033029611.6504855
Net income: 1679733656.957929
Capital expenditures: 501533009.7087379
Operating cash flow: 2004139644.0129452
Depreciation & amortization: 645271035.5987055
Net tangible assets: 7069571521.035599
Owner earnings: 1823471682.8478966
Return on net tangible assets (%): 25.793241887745722
Capex to operating income (%): 24.669242731864376
Buffett classification: The Great
Stock price: 5.030694668820678
P/E ratio: 5.918909143670008
Shares outstanding: 1976305770
Book value: 19741064077.669903
P/B ratio: 0.5036299391958639
Market cap (USD): 9942190901.098545
Debt to equity: 0.6412767184097126
Current ratio: 2.037633514878264
Quick ratio: 2.023676327529523
Effective tax rate (%): 2.260002651405019
Interest coverage ratio: 2.0538126671138017
COGS to revenue (%): 12.54866163836859
SG&A to revenue (%): 8.400502479509614
Free cash flow (dilution-adjusted): 1433692233.009709
Buyback yield (%): 0.18732725857134824
Inventory turnover: 13.469933472413816
Receivables turnover: 2.2172141515755244
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.865271179289296
FCF margin (%): 18.697097195143577
Revenue growth (%): -15.571203864697313
Rule of 40 score: 3.1258933304462637
Financial ratios for AXIA3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.030694668820678
Shares outstanding: 1976305770
Market cap (USD): 9942190901.098545
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXIA3.SA — quarterly report dated 2025-03-31
Total revenue: 1808017187.5
Gross profit: 837906250
Operating income: 478336458.3333334
Net income: -61291493.05555556
Capital expenditures: 39304861.11111111
Operating cash flow: 545026562.5
Depreciation & amortization: 193095659.72222224
Net tangible assets: 7634036979.166667
Owner earnings: 92499305.55555558
Capex to operating income (%): 8.216990452298148
Buffett classification: The Great
Stock price: 6.460069444444445
Shares outstanding: 1976305770
Book value: 21107236458.333336
P/B ratio: 0.6048670816219378
Market cap (USD): 12767072517.65625
Debt to equity: 0.604172803689414
Current ratio: 2.289620058829564
Quick ratio: 2.2718109287662327
Interest coverage ratio: 1.1971723765749935
COGS to revenue (%): 53.656068327613724
Free cash flow (dilution-adjusted): 499267361.1111111
Buyback yield (%): 0
Retained earnings: -61291493.05555556
Inventory turnover: 12.520870212108038
Receivables turnover: 0.5205598616556217
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.072248785186684
FCF margin (%): 27.614082684770448
Rule of 40 score: 27.614082684770448
Financial ratios for AXIA3.SA — quarterly report dated 2025-06-30
Total revenue: 1861122992.7007298
Gross profit: 891135036.4963503
Operating income: 821611678.8321167
Net income: -241687773.72262773
Capital expenditures: 91455839.41605839
Operating cash flow: 719236678.8321167
Depreciation & amortization: 206454197.08029196
Net tangible assets: 7564043430.656934
Owner earnings: -126689416.05839416
Return on net tangible assets (%): -1.6748901195480213
Capex to operating income (%): 11.13127305420715
Buffett classification: The Great
Stock price: 6.846715328467154
Shares outstanding: 1976305770
Book value: 21670587956.204376
P/B ratio: 0.6244040556972079
Market cap (USD): 13531203009.19708
Debt to equity: 0.6186700865081504
Current ratio: 1.8642563856294505
Quick ratio: 1.8495901447360605
Interest coverage ratio: 2.0561679118791445
COGS to revenue (%): 52.11842312456748
Free cash flow (dilution-adjusted): 615268248.1751825
Buyback yield (%): 0
Retained earnings: -306110948.90510947
Inventory turnover: 13.517380104110243
Receivables turnover: 0.5852239104093263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8144159383249974
FCF margin (%): 33.05897840111839
Revenue growth (%): 2.9372400643027543
Rule of 40 score: 35.996218465421144
Financial ratios for AXIA3.SA — quarterly report dated 2025-09-30
Total revenue: 1880169736.8421052
Gross profit: 767318984.9624059
Operating income: -1583177819.548872
Net income: -1024082142.8571428
Capital expenditures: 104048496.2406015
Operating cash flow: 792010526.3157895
Depreciation & amortization: 217222744.36090225
Net tangible assets: 6078961090.225564
Owner earnings: -910907894.7368422
Return on net tangible assets (%): -14.984598210399835
Buffett classification: The Gruesome
Stock price: 9.57330827067669
Shares outstanding: 1976305770
Book value: 20552707142.85714
P/B ratio: 0.9205495043460696
Market cap (USD): 18919784373.327065
Debt to equity: 0.6719605713540363
Current ratio: 1.9179032651957715
Quick ratio: 1.903624650336507
Interest coverage ratio: -3.992308797103641
COGS to revenue (%): 59.188845032088466
Free cash flow (dilution-adjusted): 656170112.7819549
Buyback yield (%): 0.03648963044329985
Retained earnings: -1337952067.6691728
Inventory turnover: 15.183501273334857
Receivables turnover: 0.513097959643043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.521196896218384
FCF margin (%): 34.89951465148274
Revenue growth (%): 1.0234006143643424
Rule of 40 score: 35.92291526584708
Financial ratios for AXIA3.SA — annual report dated 2025-12-31
Total revenue: 8734217153.284672
Gross profit: 6614241058.39416
Operating income: 2425224270.0729923
Net income: 1197017700.7299268
Capital expenditures: 376920437.95620435
Operating cash flow: 2647779197.0802917
Depreciation & amortization: 835204197.0802919
Net tangible assets: 7628545985.40146
Owner earnings: 1655301459.8540144
Return on net tangible assets (%): 21.698780646032937
Capex to operating income (%): 15.541673510667122
Buffett classification: The Great
Stock price: 9.08617594254937
P/E ratio: 15.001500756041882
Shares outstanding: 1976305770
Book value: 21624389963.50365
P/B ratio: 0.8304077929043252
Market cap (USD): 17957061942.49551
Debt to equity: 0.6520101402463933
Current ratio: 1.6815131188182735
Quick ratio: 1.667873098675206
Interest coverage ratio: 2.2091944790704456
COGS to revenue (%): 10.520649237801404
SG&A to revenue (%): 7.710550270968426
Free cash flow (dilution-adjusted): 2189983029.19708
Buyback yield (%): 0.03732342073822845
Inventory turnover: 11.917168781623776
Receivables turnover: 2.361438009298825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.343725221489673
FCF margin (%): 25.07360408795761
Revenue growth (%): 13.904855783192252
Rule of 40 score: 38.97845987114986
Financial ratios for AXIA3.SA — quarterly report dated 2025-12-31
Total revenue: 3147422262.773722
Gross profit: 4101106386.8613133
Operating income: 2662118613.1386857
Net income: 2497535766.4233575
Capital expenditures: 143140875.91240874
Operating cash flow: 586781751.8248174
Depreciation & amortization: 214907664.23357663
Net tangible assets: 7628545985.40146
Owner earnings: 2569302554.7445254
Return on net tangible assets (%): 33.68010836745731
Capex to operating income (%): 5.376953348582882
Buffett classification: The Great
Stock price: 9.08617594254937
P/E ratio: 15.341696157934257
Shares outstanding: 1976305770
Book value: 21624389963.50365
P/B ratio: 0.8304077929043252
Market cap (USD): 17957061942.49551
Debt to equity: 0.6520101402463933
Current ratio: 1.6815131188182735
Quick ratio: 1.667873098675206
Effective tax rate (%): -1328.454713489672
COGS to revenue (%): -68.46122600385416
Free cash flow (dilution-adjusted): 412925547.44525546
Buyback yield (%): 0
Inventory turnover: -27.94513733416007
Receivables turnover: 0.8509569240366399
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.865696855820329
FCF margin (%): 13.119483595485452
Revenue growth (%): 67.40096391829327
Rule of 40 score: 80.52044751377872
Financial ratios for AXON — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 9824000
Buffett classification: The Gruesome
Stock price: 157
Shares outstanding: 80602077
Market cap (USD): 12654526089
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXON — annual report dated 2022-12-31
Total revenue: 1187143000
Gross profit: 726113000
Operating income: 92973000
Net income: 146930000
Capital expenditures: 55802000
Operating cash flow: 235361000
Depreciation & amortization: 23116000
Net tangible assets: 1211350000
Owner earnings: 114244000
Return on net tangible assets (%): 9.431130556816775
Capex to operating income (%): 60.01957557570478
Buffett classification: The Good
Stock price: 165.93
P/E ratio: 91.02499582529096
Shares outstanding: 80602077
Book value: 1268491000
P/B ratio: 10.543474598250993
Market cap (USD): 13374302636.61
Debt to equity: 0.5605952269271126
Current ratio: 2.995586131825317
Quick ratio: 2.659616093029739
Effective tax rate (%): 25.126631946921595
Interest coverage ratio: 190.51844262295083
COGS to revenue (%): 38.83525405111263
R&D to revenue (%): 19.695184152204074
SG&A to revenue (%): 33.6379020893018
Free cash flow (dilution-adjusted): 73383000
Buyback yield (%): 0.0005532998767160907
Retained earnings: 257022000
Inventory turnover: 2.2770174494125084
Receivables turnover: 2.1386418827869975
Capitalized R&D asset: 233810000
ROCI (R&D-adjusted, %): 10.021768856520199
FCF margin (%): 6.181479400543996
Rule of 40 score: 6.181479400543996
Financial ratios for AXON — annual report dated 2023-12-31
Total revenue: 1560699000
Gross profit: 955453000
Operating income: 156850000
Net income: 175783000
Capital expenditures: 59635000
Operating cash flow: 189263000
Depreciation & amortization: 19315000
Net tangible assets: 1538281000
Owner earnings: 135463000
Return on net tangible assets (%): 8.806128399167642
Capex to operating income (%): 38.020401657634686
Buffett classification: The Good
Stock price: 258.33
P/E ratio: 118.45249285431468
Shares outstanding: 80602077
Book value: 1615765000
P/B ratio: 12.886734488870596
Market cap (USD): 20821934551.41
Debt to equity: 0.4398306684449781
Current ratio: 3.143164040187042
Quick ratio: 2.788809240235891
Effective tax rate (%): -11.920209345413566
Interest coverage ratio: 22.423159399571123
COGS to revenue (%): 38.78044389084634
R&D to revenue (%): 19.460446889502716
SG&A to revenue (%): 31.70912520607753
Free cash flow (dilution-adjusted): -1730000
Buyback yield (%): 0
Retained earnings: 434980000
Inventory turnover: 2.2428563487799003
Receivables turnover: 2.228955445141554
Capitalized R&D asset: 460371700
ROCI (R&D-adjusted, %): 9.053798586298628
Rosenberg metric: 0.9808819126641289
FCF margin (%): -0.11084776757081281
Revenue growth (%): 31.46680728437939
Rule of 40 score: 31.355959516808575
Financial ratios for AXON — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 399.6
Shares outstanding: 80602077
Market cap (USD): 32208589969.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXON — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 594.32
Shares outstanding: 80602077
Market cap (USD): 47903426402.64001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXON — annual report dated 2024-12-31
Total revenue: 2082526000
Gross profit: 1241380000
Operating income: 58540000
Net income: 377034000
Capital expenditures: 78785000
Operating cash flow: 408312000
Depreciation & amortization: 48425000
Net tangible assets: 1395670000
Owner earnings: 346674000
Return on net tangible assets (%): 24.839252831973173
Capex to operating income (%): 134.58319098052613
Buffett classification: The Gruesome
Stock price: 594.32
P/E ratio: 127.05333312815291
Shares outstanding: 80602077
Book value: 2327665000
P/B ratio: 20.580034671071655
Market cap (USD): 47903426402.64001
Debt to equity: 0.3100411786060279
Current ratio: 1.3692801907174252
Quick ratio: 1.2111539894211427
Effective tax rate (%): 1.1716784096628083
Interest coverage ratio: 8.247393632009016
COGS to revenue (%): 40.3906601886363
R&D to revenue (%): 21.204681238073377
SG&A to revenue (%): 35.59364925095773
Free cash flow (dilution-adjusted): -53077000
Buyback yield (%): 0
Retained earnings: 812014000
Inventory turnover: 3.1703553498469748
Receivables turnover: 2.2747391865219155
Capitalized R&D asset: 722242030
ROCI (R&D-adjusted, %): 4.93780109488924
Rosenberg metric: 0.9414195358209397
FCF margin (%): -2.5486836658942074
Revenue growth (%): 33.435467056748294
Rule of 40 score: 30.886783390854088
Financial ratios for AXON — quarterly report dated 2025-03-31
Total revenue: 603633000
Gross profit: 365739000
Operating income: -8793000
Net income: 87980000
Capital expenditures: 24862000
Operating cash flow: 25794000
Depreciation & amortization: 19453000
Net tangible assets: 1631137000
Owner earnings: 82571000
Return on net tangible assets (%): 5.062174421890988
Buffett classification: The Gruesome
Stock price: 525.95
P/E ratio: 120.46107751236077
Shares outstanding: 80602077
Book value: 2555853000
P/B ratio: 16.586502587648823
Market cap (USD): 42392662398.15
Debt to equity: 0.8008003590190829
Current ratio: 2.8254727215323405
Quick ratio: 2.6162370513129365
Effective tax rate (%): 18.83089924440221
Interest coverage ratio: -1.1242807825086305
COGS to revenue (%): 39.41037020838821
R&D to revenue (%): 25.019009895085258
SG&A to revenue (%): 37.0272997003146
Free cash flow (dilution-adjusted): -139307000
Buyback yield (%): 0
Retained earnings: 899994000
Inventory turnover: 0.8506269911931604
Receivables turnover: 0.619696779929328
Capitalized R&D asset: 151023000
ROCI (R&D-adjusted, %): 1.8762199952629472
FCF margin (%): -23.078095465290996
Rule of 40 score: -23.078095465290996
Financial ratios for AXON — quarterly report dated 2025-06-30
Total revenue: 668538000
Gross profit: 403743000
Operating income: -1036000
Net income: 36117000
Capital expenditures: 22953000
Operating cash flow: -91704000
Depreciation & amortization: 17157000
Net tangible assets: 1807567000
Owner earnings: 30321000
Return on net tangible assets (%): 1.6774481941748218
Buffett classification: The Gruesome
Stock price: 827.94
P/E ratio: 537.7542054310741
Shares outstanding: 80602077
Book value: 2732400000
P/B ratio: 24.423101899934125
Market cap (USD): 66733683631.380005
Debt to equity: 0.7507905138339921
Current ratio: 2.951543901606003
Quick ratio: 2.7137064971771014
Interest coverage ratio: -0.03611517813567594
COGS to revenue (%): 39.608070147097095
R&D to revenue (%): 24.31679276271506
SG&A to revenue (%): 36.230102103395765
Free cash flow (dilution-adjusted): -253901000
Buyback yield (%): 0
Retained earnings: 936111000
Inventory turnover: 0.8583528908367154
Receivables turnover: 0.6125890196567131
Capitalized R&D asset: 263752410
ROCI (R&D-adjusted, %): 1.0999939885418262
Rosenberg metric: 0.25164378935658804
FCF margin (%): -37.97854422635662
Revenue growth (%): 10.7523942527993
Rule of 40 score: -27.22614997355732
Financial ratios for AXON — quarterly report dated 2025-09-30
Total revenue: 710641000
Gross profit: 427348000
Operating income: -2129000
Net income: -2186000
Capital expenditures: 26635000
Operating cash flow: 60014000
Depreciation & amortization: 19606000
Net tangible assets: 2095316000
Owner earnings: -9215000
Return on net tangible assets (%): -0.4397904659726743
Buffett classification: The Gruesome
Stock price: 717.64
P/E ratio: 474.47133185914316
Shares outstanding: 80602077
Book value: 3027750000
P/B ratio: 19.10437603444142
Market cap (USD): 57843274538.28
Debt to equity: 0.6932986541160928
Current ratio: 3.124132974743097
Quick ratio: 2.8888911115556444
Effective tax rate (%): 113.92090683308922
Interest coverage ratio: -0.07363724405091311
COGS to revenue (%): 39.8644322520091
R&D to revenue (%): 24.86121684507367
SG&A to revenue (%): 35.57393958412194
Free cash flow (dilution-adjusted): -112773000
Buyback yield (%): 0
Retained earnings: 933925000
Inventory turnover: 0.8922248852802878
Receivables turnover: 0.5740512464255133
Capitalized R&D asset: 335431480
ROCI (R&D-adjusted, %): 0.19712095730381432
Rosenberg metric: 0.14520167069577467
FCF margin (%): -15.869194150070149
Revenue growth (%): 6.297772153564943
Rule of 40 score: -9.571421996505205
Financial ratios for AXON — annual report dated 2025-12-31
Total revenue: 2779536000
Gross profit: 1658125000
Operating income: -62076000
Net income: 124656000
Capital expenditures: 136258000
Operating cash flow: 211339000
Depreciation & amortization: 83161000
Net tangible assets: 1675497000
Owner earnings: 71559000
Return on net tangible assets (%): 4.270911854810841
Buffett classification: The Gruesome
Stock price: 567.93
P/E ratio: 367.22129372521175
Shares outstanding: 80602077
Book value: 3242658000
P/B ratio: 14.116918154985816
Market cap (USD): 45776337590.60999
Debt to equity: 0.5889193371610574
Current ratio: 2.5256331509706174
Quick ratio: 2.293131911298666
Effective tax rate (%): -556.9832402234637
Interest coverage ratio: -0.6587151679789469
COGS to revenue (%): 40.34525906482233
R&D to revenue (%): 24.6195048382176
SG&A to revenue (%): 37.26855849321613
Free cash flow (dilution-adjusted): -559150000
Buyback yield (%): 0
Retained earnings: 936670000
Inventory turnover: 3.280792601759452
Receivables turnover: 2.0436021633448913
Capitalized R&D asset: 1080402580
ROCI (R&D-adjusted, %): 2.203925399711987
Rosenberg metric: 0.9437309921126467
FCF margin (%): -20.11666695448449
Revenue growth (%): 33.469450081295506
Rule of 40 score: 13.352783126811016
Financial ratios for AXON — quarterly report dated 2025-12-31
Total revenue: 796724000
Gross profit: 461295000
Operating income: -50118000
Net income: 2745000
Capital expenditures: 61808000
Operating cash flow: 217235000
Depreciation & amortization: 26945000
Net tangible assets: 1675497000
Owner earnings: -32118000
Return on net tangible assets (%): -1.9169237545635713
Buffett classification: The Gruesome
Stock price: 567.93
P/E ratio: 367.22129372521175
Shares outstanding: 80602077
Book value: 3242658000
P/B ratio: 14.116918154985816
Market cap (USD): 45776337590.60999
Debt to equity: 0.5889193371610574
Current ratio: 2.5256331509706174
Quick ratio: 2.293131911298666
Interest coverage ratio: -1.739061036122003
COGS to revenue (%): 42.10102871257801
R&D to revenue (%): 24.35523468603933
SG&A to revenue (%): 39.834246238346026
Free cash flow (dilution-adjusted): -53169000
Buyback yield (%): 0
Retained earnings: 936670000
Inventory turnover: 0.9813288630266433
Receivables turnover: 0.585776507297907
Capitalized R&D asset: 366062690
ROCI (R&D-adjusted, %): -0.573852685260528
Rosenberg metric: 0.19214485436453582
FCF margin (%): -6.673452789171658
Revenue growth (%): 12.113429987856033
Rule of 40 score: 5.4399771986843755
Financial ratios for BIM.AX — annual report dated 2022-06-30
Operating income: -555591.724137931
Net income: -555591.724137931
Capital expenditures: 148384.1379310345
Net tangible assets: 3173544.1379310344
Owner earnings: -703975.8620689656
Return on net tangible assets (%): -22.182639707286906
Buffett classification: The Gruesome
Stock price: 0.11724137931034484
Shares outstanding: 92094233
Book value: 3173544.1379310344
P/B ratio: 3.402270280219722
Market cap (USD): 10797254.903448276
Debt to equity: 0
Current ratio: 7.015913553134863
Quick ratio: 7.015913553134863
Free cash flow (dilution-adjusted): -363244.8275862069
Buyback yield (%): 0
Retained earnings: -555591.724137931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.506979578363275
Rule of 40 score: 0
Financial ratios for BIM.AX — annual report dated 2023-06-30
Operating income: -1402594.0397350993
Net income: -1369654.3046357615
Capital expenditures: 5198.013245033113
Net tangible assets: 1690371.523178808
Owner earnings: -1374852.3178807946
Return on net tangible assets (%): -81.33432792900656
Buffett classification: The Gruesome
Stock price: 0.11258278145695365
Shares outstanding: 92094233
Book value: 1690371.523178808
P/B ratio: 6.133695915432205
Market cap (USD): 10368224.907284768
Debt to equity: 0
Current ratio: 5.678824981131171
Quick ratio: 5.678824981131171
Free cash flow (dilution-adjusted): -1613500
Buyback yield (%): 0
Retained earnings: -1903169.536423841
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -82.97548914557362
Rule of 40 score: 0
Financial ratios for BIM.AX — annual report dated 2024-06-30
Operating income: -862262.6666666666
Net income: -846546
Capital expenditures: 33656
Net tangible assets: 1036661.3333333334
Owner earnings: -880202
Return on net tangible assets (%): -84.90738216016545
Buffett classification: The Gruesome
Stock price: 0.05333333333333334
Shares outstanding: 92094233
Book value: 1038022.6666666667
P/B ratio: 4.731777623353119
Market cap (USD): 4911692.426666667
Debt to equity: 0
Current ratio: 10.350815427797135
Quick ratio: 10.350815427797135
Free cash flow (dilution-adjusted): -980618
Buyback yield (%): 0
Retained earnings: -2762403.3333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -83.06780712559905
Rule of 40 score: 0
Financial ratios for CARE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.33
Shares outstanding: 22222010
Market cap (USD): 340663413.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARE — annual report dated 2022-12-31
Total revenue: 158896000
Net income: 50118000
Capital expenditures: 5482000
Operating cash flow: 70791000
Depreciation & amortization: 6063000
Net tangible assets: 328627000
Owner earnings: 50699000
Return on net tangible assets (%): 15.42752117141927
Buffett classification: The Gruesome
Stock price: 16.53
P/E ratio: 7.329299359511553
Shares outstanding: 22222010
Book value: 328627000
P/B ratio: 1.1177712887255156
Market cap (USD): 367329825.3
Debt to equity: 0.5494070785419336
Effective tax rate (%): 18.793849344589013
COGS to revenue (%): 0
SG&A to revenue (%): 35.14751787332595
Free cash flow (dilution-adjusted): 63587000
Buyback yield (%): 11.68622775592516
Retained earnings: 285593000
Capitalized R&D asset: 0
FCF margin (%): 40.01799919444164
Rule of 40 score: 40.01799919444164
Financial ratios for CARE — annual report dated 2023-12-31
Total revenue: 137713000
Net income: 23384000
Capital expenditures: 9798000
Operating cash flow: 46730000
Depreciation & amortization: 6248000
Net tangible assets: 351243000
Owner earnings: 19834000
Return on net tangible assets (%): 5.646802925609905
Buffett classification: The Gruesome
Stock price: 14.91
P/E ratio: 14.169097207492303
Shares outstanding: 22222010
Book value: 351243000
P/B ratio: 0.9433075366626523
Market cap (USD): 331330169.1
Debt to equity: 1.1200223207295235
Effective tax rate (%): 18.58222206747676
COGS to revenue (%): 0
SG&A to revenue (%): 45.3501121898441
Free cash flow (dilution-adjusted): 35371000
Buyback yield (%): 4.954574479164143
Retained earnings: 309083000
Receivables turnover: 2.319962938005391
Capitalized R&D asset: 0
FCF margin (%): 25.684575893343403
Revenue growth (%): -13.331361393615952
Rule of 40 score: 12.353214499727452
Financial ratios for CARE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.32
Shares outstanding: 22222010
Market cap (USD): 384885213.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.52
Shares outstanding: 22222010
Market cap (USD): 389329615.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARE — annual report dated 2024-12-31
Total revenue: 132402000
Net income: 24523000
Capital expenditures: 8133000
Operating cash flow: 36938000
Depreciation & amortization: 7055000
Net tangible assets: 384313000
Owner earnings: 23445000
Return on net tangible assets (%): 6.100496210120396
Buffett classification: The Gruesome
Stock price: 17.52
P/E ratio: 15.876100607592873
Shares outstanding: 22222010
Book value: 384313000
P/B ratio: 1.0130534621519438
Market cap (USD): 389329615.2
Debt to equity: 0.1821432009846141
Effective tax rate (%): 20.557841199909294
COGS to revenue (%): 0
SG&A to revenue (%): 50.33760819322971
Free cash flow (dilution-adjusted): 27053000
Buyback yield (%): 0
Retained earnings: 333606000
Receivables turnover: 2.086713947990544
Capitalized R&D asset: 0
FCF margin (%): 20.432470808598058
Revenue growth (%): -3.856571275043024
Rule of 40 score: 16.575899533555035
Financial ratios for CARE — quarterly report dated 2025-03-31
Total revenue: 36047000
Net income: 8953000
Capital expenditures: 1523000
Operating cash flow: 6376000
Depreciation & amortization: 1911000
Net tangible assets: 401766000
Owner earnings: 9341000
Return on net tangible assets (%): 2.3249851903844525
Buffett classification: The Gruesome
Stock price: 16.12
P/E ratio: 10.002758885289847
Shares outstanding: 22222010
Book value: 401766000
P/B ratio: 0.8916105424550609
Market cap (USD): 358218801.20000005
Debt to equity: 0.1368956058999517
Effective tax rate (%): 19.60308908045977
COGS to revenue (%): 0
SG&A to revenue (%): 44.38094709684579
Free cash flow (dilution-adjusted): 4372000
Buyback yield (%): 0
Retained earnings: 342559000
Receivables turnover: 0.5652392078152196
Capitalized R&D asset: 0
FCF margin (%): 12.128609870446915
Rule of 40 score: 12.128609870446915
Financial ratios for CARE — quarterly report dated 2025-06-30
Total revenue: 36276000
Net income: 8510000
Capital expenditures: 1917000
Operating cash flow: 9599000
Depreciation & amortization: 1939000
Net tangible assets: 403369000
Owner earnings: 8532000
Return on net tangible assets (%): 2.1151848555540957
Buffett classification: The Gruesome
Stock price: 17.27
P/E ratio: 21.976413714711104
Shares outstanding: 22222010
Book value: 405635000
P/B ratio: 0.9461069993960086
Market cap (USD): 383774112.7
Debt to equity: 0.27980820195495953
Effective tax rate (%): 19.928490779074142
COGS to revenue (%): 0
SG&A to revenue (%): 45.575587165067816
Free cash flow (dilution-adjusted): 7153000
Buyback yield (%): 0
Retained earnings: 351069000
Receivables turnover: 0.5667416572928384
Capitalized R&D asset: 0
FCF margin (%): 19.71827103318999
Revenue growth (%): 0.6352817155380475
Rule of 40 score: 20.353552748728035
Financial ratios for CARE — quarterly report dated 2025-09-30
Total revenue: 38130000
Net income: 5419000
Capital expenditures: 1539000
Operating cash flow: 11815000
Depreciation & amortization: 1965000
Net tangible assets: 410638000
Owner earnings: 5845000
Return on net tangible assets (%): 1.4233948148977933
Buffett classification: The Gruesome
Stock price: 19.34
P/E ratio: 18.782172598549078
Shares outstanding: 22222010
Book value: 412838000
P/B ratio: 1.0410225642988291
Market cap (USD): 429773673.4
Debt to equity: 0.4251062159975584
Effective tax rate (%): 24.25216662007269
COGS to revenue (%): 0
SG&A to revenue (%): 42.334120115394704
Free cash flow (dilution-adjusted): 9737000
Buyback yield (%): 1.1410657058641507
Retained earnings: 356488000
Receivables turnover: 0.5994905980755927
Capitalized R&D asset: 0
FCF margin (%): 25.536323105166538
Revenue growth (%): 5.110817069136619
Rule of 40 score: 30.647140174303157
Financial ratios for CARE — quarterly report dated 2025-12-31
Total revenue: 38579000
Net income: 8741000
Capital expenditures: 3076000
Operating cash flow: 12072000
Depreciation & amortization: 2044000
Net tangible assets: 417564000
Owner earnings: 7709000
Return on net tangible assets (%): 1.8461840580126638
Buffett classification: The Gruesome
Stock price: 19.59
P/E ratio: 13.766220026562946
Shares outstanding: 22222010
Book value: 419697000
P/B ratio: 1.0372463370002645
Market cap (USD): 435329175.9
Debt to equity: 0.4253068284977019
Effective tax rate (%): 23.486420644229902
COGS to revenue (%): 0
SG&A to revenue (%): 47.67101272713134
Free cash flow (dilution-adjusted): 8474000
Buyback yield (%): 1.368619502169232
Retained earnings: 364968000
Capitalized R&D asset: 0
FCF margin (%): 21.965317919075144
Revenue growth (%): 1.1775504851822711
Rule of 40 score: 23.142868404257413
Financial ratios for CARE — annual report dated 2025-12-31
Total revenue: 149032000
Net income: 31362000
Capital expenditures: 8055000
Operating cash flow: 39862000
Depreciation & amortization: 7859000
Net tangible assets: 417564000
Owner earnings: 31166000
Return on net tangible assets (%): 7.463766033470318
Buffett classification: The Gruesome
Stock price: 19.59
P/E ratio: 13.880784895733692
Shares outstanding: 22222010
Book value: 419697000
P/B ratio: 1.0372463370002645
Market cap (USD): 435329175.9
Debt to equity: 0.4253068284977019
Effective tax rate (%): 21.5969600759981
COGS to revenue (%): 0
SG&A to revenue (%): 44.79373557356809
Free cash flow (dilution-adjusted): 29736000
Buyback yield (%): 4.594224579285774
Retained earnings: 364968000
Capitalized R&D asset: 0
FCF margin (%): 19.952761822964195
Revenue growth (%): 12.5602332291053
Rule of 40 score: 32.5129950520695
Financial ratios for CDT — annual report dated 2022-12-31
Total revenue: 0
Operating income: -3160000
Net income: -4887000
Capital expenditures: 0
Operating cash flow: -2266000
Net tangible assets: -10094000
Owner earnings: -4887000
Buffett classification: The Gruesome
Shares outstanding: 631077
Book value: -10089000
Debt to equity: -0.1992268807612251
Current ratio: 0
Quick ratio: 0
Free cash flow (dilution-adjusted): -2266000
Retained earnings: -10770000
Capitalized R&D asset: 111000
Rule of 40 score: 0
Financial ratios for CDT — annual report dated 2023-12-31
Total revenue: 0
Operating income: -5262000
Net income: 2842000
Capital expenditures: 0
Operating cash flow: -7725000
Depreciation & amortization: 0
Net tangible assets: -457000
Owner earnings: 2842000
Return on net tangible assets (%): -621.8818380743983
Buffett classification: The Gruesome
Shares outstanding: 631077
Book value: -457000
Debt to equity: -2.1553610503282274
Current ratio: 3.183231538034425
Quick ratio: 3.183231538034425
Interest coverage ratio: -24.938388625592417
Free cash flow (dilution-adjusted): -7924000
Retained earnings: -11299000
Capitalized R&D asset: 164370
ROCI (R&D-adjusted, %): -93.76504509277174
Rule of 40 score: 0
Financial ratios for CDT — quarterly report dated 2024-09-30
Capital expenditures: 41000
Buffett classification: The Gruesome
Stock price: 357000
Shares outstanding: 631077
Market cap (USD): 225294489000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDT — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -3213000
Net income: -2406000
Capital expenditures: 0
Operating cash flow: -3813000
Depreciation & amortization: 452000
Net tangible assets: -6793000
Owner earnings: -1954000
Buffett classification: The Gruesome
Stock price: 207000
Shares outstanding: 631077
Book value: -6793000
Market cap (USD): 130632939000
Debt to equity: -1.0977476814367733
Current ratio: 0.2527697607299134
Quick ratio: 0.2527697607299134
Interest coverage ratio: -3.346875
Free cash flow (dilution-adjusted): -4175000
Buyback yield (%): 0
Retained earnings: -29101000
Receivables turnover: 0
Capitalized R&D asset: 132000
Rule of 40 score: 0
Financial ratios for CDT — annual report dated 2024-12-31
Total revenue: 0
Operating income: -15105000
Net income: -17802000
Capital expenditures: 51000
Operating cash flow: -9682000
Depreciation & amortization: 457000
Net tangible assets: -6793000
Owner earnings: -17396000
Buffett classification: The Gruesome
Stock price: 207000
Shares outstanding: 631077
Book value: -6793000
Market cap (USD): 130632939000
Debt to equity: -1.0977476814367733
Current ratio: 0.2527697607299134
Quick ratio: 0.2527697607299134
Interest coverage ratio: -10.02988047808765
Free cash flow (dilution-adjusted): -11365000
Buyback yield (%): 0
Retained earnings: -29101000
Receivables turnover: 0
Capitalized R&D asset: 3474930
Rule of 40 score: 0